LobbyingIpsen Biopharmaceuticals lobbying by quarter
Ipsen Biopharmaceuticals's latest lobbying report covers Q2 2026, at $70K. The four quarters Q3 2025–Q2 2026 total $280K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Taxation/Internal Revenue Code.
Ipsen Biopharmaceuticals
- Latest quarter
- $70K
- Q2 2026 · 3 reports
- Last 12 months
- $280K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 3 |
| Q1 2023 | $70K | 3 |
| Q2 2023 | $70K | 3 |
| Q3 2023 | $70K | 3 |
| Q4 2023 | $70K | 3 |
| Q1 2024 | $70K | 3 |
| Q2 2024 | $70K | 3 |
| Q3 2024 | $70K | 3 |
| Q4 2024 | $80K | 4 |
| Q1 2025 | $90K | 4 |
| Q2 2025 | $90K | 4 |
| Q3 2025 | $70K | 3 |
| Q4 2025 | $70K | 3 |
| Q1 2026 | $70K | 3 |
| Q2 2026 | $70K | 3 |
Policy issues the reports name
- Medicare and Medicaid38 reports
- Taxation11 reports
- Pharmacy11 reports
- Health issues7 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES39 reports
- SENATE32 reports
- Natl Economic Council (NEC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Capitol Counsel | $450K | 15 quarters |
| W Strategies | $280K | 15 quarters |
| Ricchetti | $220K | 11 quarters |
| Holland & Knight | $130K | 7 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ANDREW JOSEPH SIRACUSE | Sr. Tax Cnsl., Sen. John Cornyn; Staff Dir., Sen. Fin. Cmte. Int'l. Trade, Customs & Global Comp. Sbcmte., Tax Cnsl., Sen. Cornyn; Cnsl. Sen. Cornyn; Staff Dir. Sen. Fin. Cmte, Energy, Nat. Res. Sbcmte.; LA, Sen. Cornyn; LA, Sen. Norm Coleman | Q3 2025 |
| JOHN MARTIN | Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton. | Q3 2025 |
| CHARLES PATRICK MICHAELS | Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint. | Q2 2025 |
| NICK BOUKNIGHT | Deputy Chief of Staff, Rep. Kevin McCarthy; Deputy Chief of Staff/ Communications Dir., Rep. Kevin McCarthy; Press Sec., Rep. Kevin McCarthy; Press Sec., Rep. Bill Thomas; Deputy Press Sec., Ways and Means Cmte.; Press Asst., Ways and Means Cmte. | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | W Strategies | $20K |
| 07/16for Q2 | Capitol Counsel | $30K |
| 07/10for Q2 | Holland & Knight | $20K |
| 04/19for Q1 | Capitol Counsel | $30K |
| 04/18for Q1 | W Strategies | $20K |
| 04/10for Q1 | Holland & Knight | $20K |
| 01/20for Q4 2025 | W Strategies | $20K |
| 01/18for Q4 2025 | Capitol Counsel | $30K |
| 01/13for Q4 2025 | Holland & Knight | $20K |
| 25/10/20for Q3 2025 | W Strategies | $20K |
| 25/10/17for Q3 2025 | Capitol Counsel | $30K |
| 25/10/15for Q3 2025 | Holland & Knight | $20K |
| 25/07/21for Q2 2025 | Capitol Counsel | $30K |
| 25/07/21for Q2 2025 | Ricchetti | $20K |
| 25/07/18for Q2 2025 | W Strategies | $20K |
| 25/07/13for Q2 2025 | Holland & Knight | $20K |
| 25/04/21for Q1 2025 | Capitol Counsel | $30K |
| 25/04/18for Q1 2025 | W Strategies | $20K |
| 25/04/16for Q1 2025 | Ricchetti | $20K |
| 25/04/12for Q1 2025 | Holland & Knight | $20K |